Icosavax Statistics

Total Valuation

Icosavax has a market cap or net worth of $766.88 million. The enterprise value is $545.75 million.

Market Cap	766.88M
Enterprise Value	545.75M

Important Dates

The last earnings date was Thursday, March 28, 2024, after market close.

Earnings Date	Mar 28, 2024
Ex-Dividend Date	n/a

Share Statistics

Icosavax has 50.09 million shares outstanding. The number of shares has increased by 25.87% in one year.

Shares Outstanding	50.09M
Shares Change (YoY)	+25.87%
Shares Change (QoQ)	+11.75%
Owned by Insiders (%)	3.47%
Owned by Institutions (%)	87.63%
Float	29.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.30
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 18.06, with a Debt / Equity ratio of 0.03.

Current Ratio	18.06
Quick Ratio	n/a
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	64.71

Financial Efficiency

Return on equity (ROE) is -43.10% and return on invested capital (ROIC) is -44.04%.

Return on Equity (ROE)	-43.10%
Return on Assets (ROA)	-39.50%
Return on Capital (ROIC)	-44.04%
Revenue Per Employee	n/a
Profits Per Employee	-$1.61M
Employee Count	60
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +82.26% in the last 52 weeks. The beta is 1.28, so Icosavax's price volatility has been higher than the market average.

Beta (1Y)	1.28
52-Week Price Change	+82.26%
50-Day Moving Average	15.18
200-Day Moving Average	10.11
Relative Strength Index (RSI)	55.41
Average Volume (30 Days)	1,203,625

Short Selling Information

The latest short interest is 321,311, so 0.64% of the outstanding shares have been sold short.

Short Interest	321,311
Short Previous Month	499,714
Short % of Shares Out	0.64%
Short % of Float	1.10%
Short Ratio (days to cover)	0.34

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-105.88M
Pretax Income	-96.71M
Net Income	-96.71M
EBITDA	-95.28M
EBIT	-98.23M
Earnings Per Share (EPS)	-$2.22

Full Income Statement

Balance Sheet

The company has $229.21 million in cash and $8.07 million in debt, giving a net cash position of $221.14 million or $4.41 per share.

Cash & Cash Equivalents	229.21M
Total Debt	8.07M
Net Cash	221.14M
Net Cash Per Share	$4.41
Equity / Book Value	232.38M
Book Value Per Share	4.64
Working Capital	222.28M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$68.85 million and capital expenditures -$4.83 million, giving a free cash flow of -$73.68 million.

Operating Cash Flow	-68.85M
Capital Expenditures	-4.83M
Free Cash Flow	-73.68M
FCF Per Share	-$1.47

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Icosavax does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.87%
Shareholder Yield	-25.87%
Earnings Yield	-12.61%
FCF Yield	-9.61%

Analyst Forecast

The average price target for Icosavax is $25.00, which is 63.29% higher than the current price. The consensus rating is "Buy".

Price Target	$25.00
Price Target Difference	63.29%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	182.69%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2